mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.063 |
0.7 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.071 |
0.7 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |